Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Genitourinary 1CNS 1

Conditions

Recurrence 1Prostatic Neoplasms 1Neurofibromatosis 1 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 908Carboplatin 785Paclitaxel 739pembrolizumab 738Cisplatin 707Bevacizumab 705Gemcitabine 619Docetaxel 578Rituximab 548Radiotherapy 539Dexamethasone 510Nivolumab 485Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 357Pemetrexed 334Cytarabine 334Oxaliplatin 333Lenalidomide 327Prednisone 326fludarabine phosphate 315Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Has results × Dosage Forms × Clear all
NCT05309668 2025-12-18

SPRINKLE

AstraZeneca

Phase 1/2 Active not recruiting
36 enrolled 37 charts
CNS

Neurofibromatosis 1

NCT02939183 2024-09-26

INTREPID-1

Amgen

Phase 1 Completed
61 enrolled 28 charts
Plasma cell

Multiple Myeloma, Recurrence

NCT00913068 2021-10-04

TAP

Nova Scotia Health Authority

Phase NA Completed
110 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

NCT00632424 2016-03-10

Phase 1 Trial of Oral Ixabepilone

R-Pharm

Phase 1 Terminated
23 enrolled 11 charts
Other solid neoplasm

Advanced Solid Tumors

NCT00317642 2014-04-14

A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)

Sanofi

Phase 3 Completed
326 enrolled 26 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡